Epstein Secrets

ate Indicated enterprise value (minority, marketable basis) divided by: Company indication2 Implied multiple $286,500 (63,000) 223,500 203,764 EV - Enterprise Value (invested capisol less cash): Fwd - Forward Cash and cash equivalents at the Valuation Date welt based on estimates provided by management. and incl

511,388 516,110 517,399 518,616 519,733 Full.year caprx ar % of rnwnme 3.4% 1.4% 1.4% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Remonahlenem Cheek Guideline Company Indications 0.6% to 8.7% A•crap: 2.9% Median 2.2% 35 EFTA00307430 F: F. ge"liAiAri 0000,AZA4g 00,0, 20.122q4 _zn„

ate Indicated enterprise value (minority, marketable basis) divided by: Company indication2 Implied multiple $286,500 (63,000) 223,500 203,764 EV - Enterprise Value (invested capisol less cash): Fwd - Forward Cash and cash equivalents at the Valuation Date welt based on estimates provided by management. and incl

511,388 516,110 517,399 518,616 519,733 Full.year caprx ar % of rnwnme 3.4% 1.4% 1.4% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Remonahlenem Cheek Guideline Company Indications 0.6% to 8.7% A•crap: 2.9% Median 2.2% 35 EFTA00307329 F: F. ge"liAiAri 0000,AZA4g 00,0, 20.122q4 _zn„

ate Indicated enterprise value (minority, marketable basis) divided by: Company indication2 Implied multiple $286,500 (63,000) 223,500 203,764 EV - Enterprise Value (invested capisol less cash): Fwd - Forward Cash and cash equivalents at the Valuation Date welt based on estimates provided by management. and incl

511,388 516,110 517,399 518,616 519,733 Full.year caprx ar % of rnwnme 3.4% 1.4% 1.4% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% Remonahlenem Cheek Guideline Company Indications 0.6% to 8.7% A•crap: 2.9% Median 2.2% 35 EFTA00307228 F: F. ge"liAiAri 0000,AZA4g 00,0, 20.122q4 _zn„